Amarin Corp PLC (AMRN) stock
AMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 10/3063% above fair value
$11.38−0.29 (-2.49%)
Close on Nov 13, 2026Market cap $251.55MP/E –Yield –
Amarin enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Amarin's enterprise value was -$68.71M on Nov 11, 2026, against $45.56M a year earlier. Over the last 5 years it ranged from -$109.79M to $952.98M, with a median of $41.51M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$68.71M | -1980.9% |
| 2025 | Dec 31, 2025 | $3.65M | – |
| 2024 | Dec 31, 2024 | -$106.27M | -405.6% |
| 2023 | Dec 29, 2023 | $34.78M | -81.2% |
| 2022 | Dec 30, 2022 | $184.93M | -78.3% |
| 2021 | Dec 31, 2021 | $854.08M | -36.7% |
| 2020 | Dec 31, 2020 | $1.35B | -80.9% |
| 2019 | Dec 31, 2019 | $7.05B | +70.3% |
| 2018 | Dec 31, 2018 | $4.14B | +275.5% |
| 2017 | Dec 29, 2017 | $1.10B | +35.6% |
| 2016 | Dec 30, 2016 | $813.63M | +144.7% |
| 2015 | Dec 31, 2015 | $332.52M | +139.9% |
| 2014 | Dec 31, 2014 | $138.61M | -31.2% |
| 2013 | Dec 31, 2013 | $201.54M | -82.1% |
| 2012 | Dec 31, 2012 | $1.13B | +26.6% |
| 2011 | Dec 30, 2011 | $891.55M | – |
See a number that looks wrong?